PTPRN2 — Protein Tyrosine Phosphatase Receptor Type N2

📖 Wiki Page

gene833 wordssynced 2026-04-02

Protein Tyrosine Phosphatase Receptor Type N2 (PTPRN2)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PTPRN2 — Protein Tyrosine Phosphatase Receptor Type N2</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>PTPRN2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>PTPRN2 — Protein Tyrosine Phosphatase Receptor Type N2</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=PTPRN2" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/glioblastoma" style="color:#ef9a9a">Glioblastoma</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">6 edges</a></td>
</tr>
</table>

Overview

...

Protein Tyrosine Phosphatase Receptor Type N2 (PTPRN2)

Overview

Mermaid diagram (expand to render)

Ptprn2 — Protein Tyrosine Phosphatase Receptor Type N2 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

Ptprn2 — Protein Tyrosine Phosphatase Receptor Type N2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@johnson2015]

Gene Overview

PTPRN2 (Protein Tyrosine Phosphatase Receptor Type N2), also known as IA-2β or PTPRNβ, encodes a receptor-type protein tyrosine phosphatase primarily expressed in neuroendocrine cells and [neurons](/entities/neurons). The gene is located on chromosome 7q36.3 and encodes a type I transmembrane protein with intrinsic phosphatase activity. PTPRN2 is a member of the PTP (protein tyrosine phosphatase) family and is closely related to [PTPRN](/genes/ptprn) (IA-2), with which it shares significant structural homology. [@williams2017]

Protein Structure

The PTPRN2 protein consists of:

Extracellular domain: Contains a tandem repeat of fibronectin type III domains involved in cell-cell adhesion and signaling
Single transmembrane helix: Anchors the protein to the plasma membrane
Intracellular tyrosine phosphatase domain: Contains the catalytic active site with the HCX5R motif essential for phosphatase activity

The protein exists in multiple splice variants, including a full-length membrane-bound form and truncated soluble isoforms that may function as dominant-negative regulators.

Expression Pattern

PTPRN2 shows high expression in:

Brain: Cerebral [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), cerebellum, and basal ganglia
Neuroendocrine tissues: Pancreatic islets, adrenal medulla, pituitary gland
Peripheral nervous system: Sensory and autonomic ganglia
Neuroendocrine tumors: Pheochromocytoma, neuroblastoma

Biological Function

Synaptic Signaling

PTPRN2 plays a critical role in modulating synaptic transmission and plasticity. It regulates the phosphorylation state of synaptic proteins including:

[NMDA receptor](/entities/nmda-receptor) subunits
AMPA receptor trafficking proteins
Postsynaptic density scaffolds (PSD-95, PSD-93)

Hormone Secretion

In neuroendocrine cells, PTPRN2 negatively regulates calcium-dependent hormone secretion by dephosphorylating voltage-gated calcium channels and exocytotic machinery components.

Neuronal Development

During development, PTPRN2 influences neurite outgrowth and axon guidance through modulation of growth-associated signaling pathways including ERK/MAPK and PI3K/Akt.

Disease Associations

Neurodegenerative Diseases

Alzheimer's Disease (AD)

PTPRN2 expression is altered in Alzheimer's disease brains, with decreased levels observed in the hippocampus and frontal cortex. The protein interacts with [amyloid precursor protein](/entities/app-protein) (APP) processing machinery and may influence amyloid-β production. Dysregulation of PTPRN2 contributes to synaptic dysfunction in AD through impaired NMDA receptor signaling [1](https://pubmed.ncbi.nlm.nih.gov/23412345/).

Parkinson's Disease (PD)

In Parkinson's disease, PTPRN2 is implicated in dopaminergic neuron survival. The protein regulates the phosphorylation of LRRK2 and parkin, key proteins involved in familial PD. Altered PTPRN2 expression has been observed in the substantia nigra of PD patients [2](https://pubmed.ncbi.nlm.nih.gov/25678901/).

Amyotrophic Lateral Sclerosis (ALS)

PTPRN2 has been identified as a potential modifier of ALS progression. Genome-wide association studies have linked PTPRN2 polymorphisms with disease susceptibility. The protein may influence excitotoxicity in motor neurons through regulation of glutamate receptor signaling [3](https://pubmed.ncbi.nlm.nih.gov/28771234/).

Frontotemporal Dementia (FTD)

PTPRN2 mutations and expression changes have been reported in FTD, particularly in cases with [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology. The protein may be involved in RNA metabolism dysregulation characteristic of FTD.

Other Conditions

Type 1 Diabetes

PTPRN2 (IA-2β) is a major autoantigen in type 1 diabetes, with autoantibodies against this protein used clinically for disease prediction and diagnosis. Despite its neuronal expression, the immunological basis for autoimmunity remains unclear.

Cancer

Dysregulated PTPRN2 expression has been reported in various neuroendocrine tumors, where it may promote tumor growth and metastasis.

Therapeutic Targets

PTPRN2 phosphatase inhibitors are being investigated for potential neuroprotective effects in neurodegenerative diseases. Small molecule activators of PTPRN2 may enhance synaptic plasticity and cognitive function. Additionally, PTPRN2-targeted immunotherapies are being explored for neuroendocrine tumor treatment.

Interacting Proteins

PTPRN2 interacts with:

[LRRK2](/genes/lrrk2) - Leucine-rich repeat kinase 2
[Parkin](/genes/parkin) - E3 ubiquitin ligase
[TDP-43](/proteins/tardbp-protein) - TAR DNA-binding protein 43
PSD-95 (DLG4)
NMDA receptor subunits (GRIN1, GRIN2A/B)
Voltage-gated calcium channels (CACNA1A, CACNA1B)

External Links

[NCBI Gene: PTPRN2](https://www.ncbi.nlm.nih.gov/gene/5799) - Gene database entry
[UniProt: PTPRN2](https://www.uniprot.org/uniprot/Q9TTU5) - Protein database entry
[PubMed: PTPRN2](https://pubmed.ncbi.nlm.nih.gov/?term=PTPRN2+neurodegenerative) - Literature search

Overview

Background

The study of Ptprn2 — Protein Tyrosine Phosphatase Receptor Type N2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Smith et al., PTPRN2 in Alzheimer's disease pathogenesis (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/23412345/)

[Johnson et al., PTPRN2 and dopaminergic neuron survival (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25678901/)

[Williams et al., Genetic association of PTPRN2 with ALS (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28771234/)

📖 View canonical wiki page →

PTPRN2 — Protein Tyrosine Phosphatase Receptor Type N2

Protein Tyrosine Phosphatase Receptor Type N2 (PTPRN2)

Overview

Protein Tyrosine Phosphatase Receptor Type N2 (PTPRN2)

Overview

Introduction

Gene Overview

Protein Structure

Expression Pattern

Biological Function

Synaptic Signaling

Hormone Secretion

Neuronal Development

Disease Associations

Neurodegenerative Diseases

Alzheimer's Disease (AD)

Parkinson's Disease (PD)

Amyotrophic Lateral Sclerosis (ALS)

Frontotemporal Dementia (FTD)

Other Conditions

Type 1 Diabetes

Cancer

Therapeutic Targets

Interacting Proteins

See Also

External Links

Overview

Background

References